UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cell-Free DNA and Active Rejection in Kidney Allografts

Journal of the American Society of Nephrology, 2017-07, Vol.28 (7), p.2221-2232

2017

Volltextzugriff (PDF)

Systematic identification of cis-regulatory sequences active in mouse and human embryonic stem cells

PLoS genetics, 2007-08, Vol.3 (8), p.e145-e145

2007

Volltextzugriff (PDF)

A Dual Inhibitory Mechanism Restricts msl-2 mRNA Translation for Dosage Compensation in Drosophila

Cell, 2005-08, Vol.122 (4), p.529-540

2005

Volltextzugriff (PDF)

Induced pluripotent stem cells in the study of neurological diseases

Stem cell research & therapy, 2011-09, Vol.2 (5), p.37-37, Article 37

2011

Volltextzugriff (PDF)

Induced pluripotent stem cells — opportunities for disease modelling and drug discovery

Nature reviews. Drug discovery, 2011-12, Vol.10 (12), p.915-929

2011

Volltextzugriff (PDF)

A simple method for RNA isolation from formalin-fixed and paraffin-embedded lymphatic tissues

Experimental and molecular pathology, 2003-06, Vol.74 (3), p.336-340

2003

Volltextzugriff (PDF)

Performance of Donor-derived Cell-free DNA Assays in Kidney Transplant Patients

Transplantation, 2020-05, Vol.104 (5), p.e135-e135

2020

Volltextzugriff (PDF)

232.5: Identification of the Source of Donor Derived Cell-free DNA in A Kidney-pancreas Transplant Recipient: Case Study

Transplantation, 2022-09, Vol.106 (9S), p.S80-S80

2022

Volltextzugriff (PDF)

Acrobat: A Multicenter Prospective Study to Monitor Chimerism in Post Allogeneic Hemopoietic Cell Transplant Patients with AML, ALL, or MDS for Prediction of Engraftment and Relapse

Blood, 2022-11, Vol.140 (Supplement 1), p.13005-13006

2022

Volltextzugriff (PDF)

Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice

Cell stem cell, 2012-05, Vol.10 (5), p.610-619

2012

Volltextzugriff (PDF)

Quantification of Chimerism and Graft Immune Cell Composition with Alloseq HCT, a Highly Sensitive and Precise Next-Generation Sequencing Assay, in Patients Post-Hematopoietic Stem Cell Transplantation

Blood, 2020-11, Vol.136 (Supplement 1), p.35-35

2020

Volltextzugriff (PDF)

Universal Sensitive, Accurate and Precise Microchimerism Surveillance Solution for Allogeneic Hematopoietic Cell Transplant

Blood, 2020-11, Vol.136 (Supplement 1), p.32-33

2020

Volltextzugriff (PDF)

A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells

Molecular and cellular neuroscience, 2013-09, Vol.56, p.355-364

2013

Volltextzugriff (PDF)

Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients

The Journal of molecular diagnostics : JMD, 2016-11, Vol.18 (6), p.890-902

2016

Volltextzugriff (PDF)

Donor-derived posttransplant lymphoproliferative disease detection by donor-derived cell-free DNA

American journal of transplantation, 2024-09

2024

Volltextzugriff (PDF)

Reprogramming of T Cells from Human Peripheral Blood

Cell stem cell, 2010-07, Vol.7 (1), p.15-19

2010

Volltextzugriff (PDF)

Repeat kidney transplant recipients with active rejection have elevated donor‐derived cell‐free DNA

American journal of transplantation, 2019-05, Vol.19 (5), p.1597-1598

2019

Volltextzugriff (PDF)

DETECTION OF DONOR-DERIVED CELL-FREE DNA: NON-INVASIVE PREDICTION OF SILENT ANTIBODY-MEDIATED REJECTION IN DONOR-SPECIFIC ANTIBODY-POSITIVE RENAL ALLOGRAFT RECIPIENTS

Transplantation, 2020-09, Vol.104 (S3), p.S356-S356

2020

Volltextzugriff (PDF)

565 - Advances in Chimerism Monitoring Using NGS Technology: Design of the Acrobat Multicenter Clinical Trial

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S438-S438

2022

Volltextzugriff (PDF)

Advances in Chimerism Monitoring Using NGS Technology: Design of the Acrobat Multicenter Clinical Trial

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S438

2022

Volltextzugriff (PDF)

Micro-Chimerism Detected By Highly Sensitive AlloHemeTM Solution Is Associated with Treatment Response and Relapse after Allogeneic Stem Cell Transplantation

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S403-S404

2024

Volltextzugriff (PDF)

Donor-derived post-transplant lymphoproliferative disease detection by donor-derived cell free DNA

American journal of transplantation, 2024-09

2024

Volltextzugriff (PDF)

Post-Allogeneic HCT Microchimerism Monitoring Solution with High Accuracy and Sensitivity

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S148

2021

Volltextzugriff (PDF)

298 - Allocell Provides a Highly Accurate, Sensitive, and Universal Solution for Monitoring Expansion and Persistence of Allogeneic Cellular Therapies

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S234-S234

2022

Volltextzugriff (PDF)

Allocell Provides a Highly Accurate, Sensitive, and Universal Solution for Monitoring Expansion and Persistence of Allogeneic Cellular Therapies

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S234

2022

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(42)
Buchkapitel
(1)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cell-Free DNA and Active Rejection in Kidney Allografts

Systematic identification of cis-regulatory sequences active in mouse and human embryonic stem cells

A Dual Inhibitory Mechanism Restricts msl-2 mRNA Translation for Dosage Compensation in Drosophila

Induced pluripotent stem cells in the study of neurological diseases

Induced pluripotent stem cells — opportunities for disease modelling and drug discovery

A simple method for RNA isolation from formalin-fixed and paraffin-embedded lymphatic tissues

Performance of Donor-derived Cell-free DNA Assays in Kidney Transplant Patients

232.5: Identification of the Source of Donor Derived Cell-free DNA in A Kidney-pancreas Transplant Recipient: Case Study

Acrobat: A Multicenter Prospective Study to Monitor Chimerism in Post Allogeneic Hemopoietic Cell Transplant Patients with AML, ALL, or MDS for Prediction of Engraftment and Relapse

Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice

Quantification of Chimerism and Graft Immune Cell Composition with Alloseq HCT, a Highly Sensitive and Precise Next-Generation Sequencing Assay, in Patients Post-Hematopoietic Stem Cell Transplantation

Universal Sensitive, Accurate and Precise Microchimerism Surveillance Solution for Allogeneic Hematopoietic Cell Transplant

A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells

Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients

Donor-derived posttransplant lymphoproliferative disease detection by donor-derived cell-free DNA

Reprogramming of T Cells from Human Peripheral Blood

Repeat kidney transplant recipients with active rejection have elevated donor‐derived cell‐free DNA

DETECTION OF DONOR-DERIVED CELL-FREE DNA: NON-INVASIVE PREDICTION OF SILENT ANTIBODY-MEDIATED REJECTION IN DONOR-SPECIFIC ANTIBODY-POSITIVE RENAL ALLOGRAFT RECIPIENTS

565 - Advances in Chimerism Monitoring Using NGS Technology: Design of the Acrobat Multicenter Clinical Trial

Advances in Chimerism Monitoring Using NGS Technology: Design of the Acrobat Multicenter Clinical Trial

Micro-Chimerism Detected By Highly Sensitive AlloHemeTM Solution Is Associated with Treatment Response and Relapse after Allogeneic Stem Cell Transplantation

Donor-derived post-transplant lymphoproliferative disease detection by donor-derived cell free DNA

Post-Allogeneic HCT Microchimerism Monitoring Solution with High Accuracy and Sensitivity

298 - Allocell Provides a Highly Accurate, Sensitive, and Universal Solution for Monitoring Expansion and Persistence of Allogeneic Cellular Therapies

Allocell Provides a Highly Accurate, Sensitive, and Universal Solution for Monitoring Expansion and Persistence of Allogeneic Cellular Therapies

Suchergebnisse filtern